Fig. 3: Maturity of ML platforms across areas of active research in the pharmaceutical industry.
From: Challenges and opportunities in computational studies for lipid nanoparticle development
As one traverses from left to right the maturity of ML method development declines, while at the same time the inherent complexity of research data being generated increases. ML methods are just beginning to be explored in nanomedicine. We expect the impact of ML methods to be greater when data complexity increases.
